All Grant Programs

The Child Health Collaborative Grant Award supports collaborative research that addresses important, unmet child health issues in Minnesota by developing and translating innovative, evidence-based health improvement strategies. CTSI, in partnership with the University's Department of Pediatrics and Children’s Hospitals and Clinics of Minnesota, teamed up to create this grant program as part of a broader effort to support research partnerships among community and University child health researchers. 

The program provides funding to help University of Minnesota faculty prepare and implement prospective clinical pilot studies. It is expected that data gathered through this funding mechanism will be used to inform the design of subsequent larger clinical trials. 

The goal of the Committee for Pharmaceutical Development (CPD) is to identify, develop, and commercialize pharmaceutical products by forming networks and fostering dialogue between University of Minnesota researchers and industry experts. The CPD aims to boost the success rate of therapeutic development and commercialization. The Office of the Vice President for Research and the Office of the Vice President for Health Sciences serve as the sponsors of the CPD, which includes University staff and external advisors with proven drug-development experience.

Provides funding for the development of novel pediatric medical device technologies that address unmet medical needs submitted by members of the community. 

The Community Health Collaborative Grants Program is designed to support research projects that ultimately lead to health improvements, while building and sustaining community-University research partnerships. It supports health research collaborations between University of Minnesota investigators and individuals or groups from outside the University, such as nonprofits, health care providers, and community advocates.  

The program provides funding and operational support for industry and university researcher teams to solve a current pediatric medical need through developing or moving pediatric medical device technologies forward. CTSI’s Office of Discovery and Translation (ODAT) has partnered with the Pediatric Device Innovation Consortium (PDIC) to offer this program. Applications are accepted on a continuous basis. 

The program, previously named the Pediatric Medical Device Translational Grant Program, supports the development of pediatric medical devices, with the ultimate goal of improving pediatric patient outcomes and quality of life through technology-driven medical solutions. The program’s partners, CTSI’s Office of Discovery and Translation (ODAT) and the Pediatric Device Innovation Consortium (PDIC), will provide funded investigators with work strategy guidance, frequent feedback, and access to comprehensive internal and external services. Application cycle is currently closed.

The Office of Discovery and Translation (ODAT) Translational Grant Program awards funding to University of Minnesota research projects that aim to translate basic science discoveries into patient benefit, with the overarching goal of positively impacting human health. In addition to funds, awarded projects will also receive the support of a project development team with the appropriate expertise to determine critical project milestones, identify key gaps, and strengthen the likelihood for progress toward eventual development into a new product or treatment approach. The program is currently accepting applications. 

Translational Product Development Fund

The Translational Product Development Fund (TPDF) supports health research projects that are intended to lead to the development of a novel therapeutic, device, diagnostic, or IT product, and have the potential to be commercialized through the formation of a start-up company or license to an established commercial entity. Ultimately, the program, which is a collaborative grant initiative between CTSI’s Office of Discovery and Translation and the Mayo Clinic Center for Clinical and Translational Science (CCaTS) in conjunction with the Minnesota Partnership for Biotechnology and Medical Genomics (MNP), aims to impact the lives of Minnesotans by translating research discoveries into new therapies and treatment approaches for patients.